BusinessPreclinical Data Showing Synergy of Biothera Pharmaceuticals’ Imprime PGG and a CD40 Agonist in a Pancreatic Cancer Model Presented at Keystone SymposiaBy Nasdaq OMXMar 26, 2018, 2:00 PM UTC